Mirae Asset Global Etfs Holdings Ltd. Inmune Bio, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 7,514 shares of INMB stock, worth $10,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,514
Previous 9,118
17.59%
Holding current value
$10,895
Previous $21,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding INMB
# of Institutions
83Shares Held
5.34MCall Options Held
310KPut Options Held
371K-
Vanguard Group Inc Valley Forge, PA958KShares$1.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.18 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$864,73945.87% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$680,6880.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$535,6850.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $26M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...